In this multi-center trial, Stage 1-3 patients having mastectomies or isolated lumpectomy
with axillary node dissection will be randomly assigned to thoracic epidural or paravertebral
anesthesia/analgesia, or to general anesthesia and morphine analgesia. Participants will be
followed for up to 10 years to determine the rate of cancer recurrence or metastasis.